Ed Jarman

Postdoctoral researcher working on Wnt signalling in cholangiocarcinoma and liver biology at the University of Edinburgh.

[Ed Jarman @EdJarman2]

@CharityAMMF @EdinburghUni Such a pleasure to present! Thank you AMMF for the opportunity, and a wonderful conference.

[Liver Growth and Cancer Lab @boulter_lab]

Very pleased to say that our latest #preprint on #cholangiocarcinoma is now online. A short summary 🧵

[Ed Jarman @EdJarman2]

@CharityAMMF A thoroughly enjoyable online conference! Many thanks to speakers/presenters, organisers and Q&A facilitators!

[Liver Growth and Cancer Lab @boulter_lab]

The latest offering from our lab. Wnt signalling regulates ductular scarring through non-canonical signalling. Thank you to all of those lab members past and present who contributed to the work - you're awesome!
https://t.co/uJNhs3BuPF

[Ed Jarman @EdJarman2]

Chuffed to receive this, thanks again for organising a fantastic conference!

[AMMF @CharityAMMF]

#AMMF is delighted to help fund the research work of Dr Toby Phesse at the European Cancer Stem Cell Research Institute, Cardiff University, into investigative cell signaling pathways in #cholangiocarcinoma.

[Liver Growth and Cancer Lab @boulter_lab]

As @PDTsokkou’s MScR draws to a close, I’m proud to say that she has produced some excellent data under @EdJarman2’s mentorship. Example of said mentorship below.

[Liver Growth and Cancer Lab @boulter_lab]

We are enormously proud of @EdJarman2 for his @curecc fellowship. Very generously supported by Janice and Dean Meyer. #cholangiocarcinoma #ammf @mrc_hgu @MRC_IGMM

[Ed Jarman @EdJarman2]

Our paper “HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer” has just been published in Breast Cancer Research. Check it out here: https://t.co/MiTXFLRQnv #BCRJournal #breastcancer #hypoxia #research #MRC_IGMM #EdinburghUni